Effects of 5,6-benzoflavone, indole-3-carbinol (I3C) and diindolylmethane (DIM) on chemically-induced mammary carcinogenesis: Is DIM a substitute for I3C?

Oncology Reports

Volumn 26, Issue 3, 2011, Pages 731-736

  Lubet, Ronald A ^a   Heckman, Brandy M ^a   De Flora, Silvio L ^b   Steele, Vernon E ^a   Crowell, James A ^a   Juliana, M Margaret ^c   Grubbs, Clinton J ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

5,6 benzoflavone; Ah receptors; Diindolylmethane; Indole 3 carbinol; Mammary cancer

Indexed keywords

3 INDOLEMETHANOL; ANTINEOPLASTIC AGENT; AROMATIC HYDROCARBON RECEPTOR; BETA NAPHTHOFLAVONE; DIINDOLYLMETHANE; DIMETHYLBENZ[A]ANTHRACENE; METHYLNITROSOUREA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER INHIBITION; CONTROLLED STUDY; DNA ADDUCT; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG STRUCTURE; DRUG TARGETING; NONHUMAN; PRIORITY JOURNAL; RAT;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ANTICARCINOGENIC AGENTS; ARYL HYDROCARBON HYDROXYLASES; BETA-NAPHTHOFLAVONE; CYTOCHROME P-450 CYP1A1; EPITHELIAL CELLS; FEMALE; INDOLES; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; METHYLNITROSOUREA; RATS; RATS, SPRAGUE-DAWLEY; TRANSCRIPTION, GENETIC; TUMOR BURDEN;

EID: 79959958115     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1316     Document Type: Article

References (32)

1. Wattenberg LW, Page MA and Leong JL: Induction of increased benzopyrene hydroxylase activity by flavones and related compounds. Cancer Res 28: 934-937, 1968.
2. Boobis AR, Nebert DW and Felton JS: Comparison of β-naphthoflavone and 3-methylcholanthrene as inducers of hepatic cytochrome(s) P448 and aryl hydrocarbon(benzo[a]pyrene) hydroxylase activity. Mol Pharmacol 13: 259-268, 1977. (Pubitemid 8076771)
3. Wattenberg LW and Leong JL: Inhibition of the carcinogenic action of 7,12-dimethylbenzanthracene by beta-napthoflavone. Proc Soc Exp Biol Med 128: 940-943, 1968.
4. Diamond L, McFall R, Miller J and Gelboin HV: The effects of two isomeric benzoflavones on aryl hydrocarbon hydroxylase and the toxicity and carcinogenicity of polycyclic hydrocarbons. Cancer Res 32: 731-736, 1972.
5. Nixon JE, Hendricks JD, Pawlowski NE, Pereira CB, Sinnhuber RO and Bailey GS: Inhibition of aflatoxin Bl carcinogenesis in rainbow trout by flavone and indole compounds. Carcinogenesis 5: 615-619, 1984. (Pubitemid 14108570)
6. Guo D, Schut HA, Davis CD, Synderwine EG, Bailey GS and Dashwood RH: Protection by chlorophyllin and indole-3-carbinol against 2-amino-1-methyl-6- phenylimidazo (4,5-b)pyridine (PhlP) induced DNA adducts and colonic aberrant crypts in the F344 rat. Carcinogenesis 16: 2391-2397, 1995.
7. Morse MA, La Greca SD, Amin SG and Chung FL: Effects of indole-3-carbinol on lung tumorigenesis and DNA methylation induced by 4-(methylnitrosamino)-1- (3-pyridyl)-1-butanone (NNK) and on the metabolism and disposition of NNK in A/J mice. Cancer Res 50: 2613-2617, 1990. (Pubitemid 20150192)
8. Dashwood RH, Arbogast DN, Fong AT, Pereira C, Hendricks JD and Bailey GS: Quantitative interrelationship between aflatoxin B1 carcinogen dose, indole-3-carbinol anti-carcinogen dose, target organ DNA adduction and final tumor response. Carcinogenesis 1: 175-181, 1989. (Pubitemid 19032102)
9. Tanaka T, Kojima T, Morishita Y and Mori H: Inhibitory effects of the natural products indole-3-carbinol and singrin during initiation and promotion phases of 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis. Jpn J Cancer Res 83: 835-842, 1992.
10. Ip C, Vadhanavikit S and Ganther H: Cancer chemoprevention by aliphatic selenocyanates: effect of chain length on inhibition of mammary tumors and DMBA adducts. Carcinogenesis 16: 35-38, 1995.
11. Singletary KW, MacDonald C and Wallig M: The plasticizer benzyl butyl phthalate (BBP) inhibits 7,12-dimethylbenz[a] anthracene (DMBA)-induced rat mammary DNA adduct formation and tumorigenesis. Carcinogenesis 18: 1669-1973, 1997.
12. Izzotti A, Camoirano A, Cartiglia C, et al: Patterns of DNA adduct formation in liver. Cancer Res 59: 4285-4290, 1999.
13. Bradlow HL, Minchovicz JJ, Telang NT and Osborne MP: Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice. Carcinogenesis 12: 1571-1574, 1991.
14. Kojima T, Tanaka T and Mori H: Chemoprevention of spontaneous endometrial cancer in female Donryu rats by dietary indole-3-carbinol. Cancer Res 54: 1446-1449, 1994. (Pubitemid 24106404)
15. Martucci CP and Fishman J: P450 enzymes of estrogen metabolism. Pharmacol Ther 57: 237-257, 1993. (Pubitemid 23175382)
16. Zhu BT and Conney AH: Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis. Cancer Res 58: 2269-2277, 1998. (Pubitemid 28252677)
17. Chen I, McDougal A, Wang F and Safe S: Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane. Carcinogenesis 19: 1631-1639, 1998. (Pubitemid 28441867)
18. Bjeldanes LF, Kim JY, Grose KR, Bartholomew JC and Bradfield CA: Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8-tetrachlorodibnezo-p-dioxin. Proc Natl Acad Sci USA 88: 2543-2547, 1993.
19. Le HT, Schaldach C, Firestone GL and Bjeldanes LF: Plant-derived 3, 1′-diindolylmethane is a strong androgen antagonist in human prostate cancer cells. J Biol Chem 278: 21136-21145, 2003. (Pubitemid 36806427)
20. Grubbs CJ, Steele VE and Casebolt T: Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol. Anticancer Res 15: 709-716, 1995.
21. 32P-post-labeling test for structurally diverse DNA adducts. Carcinogenesis 7: 1543-1551, 1996.
22. Izzotti A, D'Agostini F, Bagnasco M, et al: Chemoprevention of carcinogen-DNA adducts and chronic degenerative diseases. Cancer Res 54: 1994S-1998S, 1994.
23. 32P-post-labeling analysis of aromatic carcinogen: DNA adducts. Cancer Res 45: 5656-5662, 1985.
24. Lubet RA, Yao R, Grubbs CJ, You M and Wang Y: Induced expression of drug metabolizing enzymes by preventive agents: role of the antioxidant response element. Chem Biol Interact 182: 22-28, 2009.
25. Armitage P: The chi square test for heterogeneity of proportion after adjusting for stratification. J R Stat Soc B 28: 150-163, 1966.
26. Vericat JA, Cheng SC and Dipple A: Absolute stereochemistry of the major 7,12-dimethylbenz[alpha]anthracene-DNA adducts formed in mouse cells. Carcinogenesis 10: 567-570, 1989. (Pubitemid 19089926)
27. Wortelboer HM, van der Linden EC, De Kruif CA, et al: Effects of indole-3-carbinol on biotransformation enzymes in the rat: in vivo changes in liver and small intestinal mucosa in comparison with primary rat hepatocyte cultures. Food Chem Toxicol 30: 589-599, 1992.
28. Chen I, Safe S and Bjeldanes L: Indole-3-carbinol and diindolyl-methane as aryl hydrocarbon (Ah) receptor agonists and antagonists in T47D human breast cancer cells. Biochem Pharmacol 51: 1069-1076, 1996. (Pubitemid 26104627)
29. Malejka-Giganti D, Benett K, Culp SJ and Beland RA: Metabolic aspects of inhibition by 5,6-benzoflavone on mammary tumorigenesis in the rat. Proc Am Assoc Cancer Res 37: 265, 1996.
30. Parkinson A and Hurwitz A: Omeprazole and the induction of human cytochrome P450: a response to concerns about potential adverse effects. Gastroenterology 100: 1157-1164, 1991.
31. Bailey GS, Hendericks JD, Shelton DW, Nixon JE and Pawlowski NE: Enhancement of carcinogenesis by the natural anticarcinogen indole-3-carbinol. J Natl Cancer Inst 78: 931-934, 1987. (Pubitemid 17093018)
32. Kawajiri K, Kobayashi Y, Ohtake F, et al: Aryl hydrocarbon receptor suppresses intestinal carcinogenesis in ApcMin/+ mice with natural ligands. Proc Natl Acad Sci USA 106: 13481-13486, 2009.